Dark

Check out our Level2View

NUVA
NuVasive, Inc.
stock NASDAQ

Inactive

Aug 31, 2023

39.75USD-2.238%(-0.91)31,368,558

Pre-market

0.00USD-100.000%(-40.66)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 31, 2022

04:12PM EST NuVasive Appoints Andrew Morton As Chief Human Resources Officer RTTNews

Jan 7, 2022

01:09PM EST Where NuVasive Stands With Analysts Benzinga

01:07PM EST Morgan Stanley Maintains Equal-Weight on NuVasive, Lowers Price Target to $60 Benzinga

Jan 5, 2022

07:08AM EST NuVasive: FDA Approves Expanded Indications Of Attrax RTTNews

07:02AM EST NuVasive Gets FDA Clearance For Expanded Indications Of Use For Attrax Putty With Thoracolumbar Interbody Portfolio RTTNews

07:02AM EST NuVasive Receives FDA Clearance For Expanded Indications Of Use For Attrax Putty With Company's Thoracolumbar Interbody Portfolio Benzinga

07:01AM EST NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax PR Newswire

Dec 28, 2021

07:01AM EST NuVasive to Participate in 40th Annual J.P. Morgan Healthcare Conference PR Newswire

Dec 21, 2021

07:24AM EST Truist Securities Maintains Buy on NuVasive, Lowers Price Target to $60 Benzinga

Dec 13, 2021

11:09AM EST Why Did BofA Securities Give Globus Medical A Double Upgrade? Benzinga

Dec 10, 2021

12:41PM EST Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 Benzinga

04:56AM EST RBC Capital Initiates Coverage On NuVasive with Outperform Rating, Announces Price Target of $60 Benzinga

Dec 1, 2021

11:46AM EST FDA Says It Believes It Is In The Best Interest Of Patients To Make Titanium-Based Precise Devices Available In U.S.; Nuvasive Is Looking Into Issues With Stainless-Steel Based Precise Devices Benzinga

Nov 18, 2021

07:01AM EST NuVasive to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference PR Newswire

Nov 15, 2021

12:57PM EST BZ NOTE: Globus Medical Said To Make Early Takeover Approach For Nuvasive Benzinga

Nov 10, 2021

07:18AM EST NuVasive's Q3 Earnings Hit By COVID-19, Staff Shortage; Cuts FY21 Guidance Benzinga

05:42AM EST Needham Maintains Buy on NuVasive, Lowers Price Target to $64 Benzinga

Nov 9, 2021

05:13PM EST NuVasive Sees FY21 $1.132B-$1.142B Vs $1.19B Benzinga

05:10PM EST NuVasive Q3 EPS $0.32 Misses $0.54 Estimate, Sales $270.84M Miss $291.79M Estimate Benzinga

05:04PM EST NuVasive: Q3 Earnings Insights Benzinga

04:16PM EST NuVasive, Inc. (NUVA) Announces $100 Mln Stock Buyback RTTNews

04:12PM EST NuVasive Q3 Loss/share $0.42 Vs. Profit $0.11 Year Ago RTTNews

04:10PM EST NuVasive Announces Third Quarter 2021 Financial Results PR Newswire

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Nov 1, 2021

07:01AM EDT NuVasive to Present at Credit Suisse 30th Annual Healthcare Conference PR Newswire

Oct 28, 2021

07:02AM EDT NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine PR Newswire

Oct 27, 2021

12:23PM EDT Needham Maintains Buy on NuVasive, Lowers Price Target to $73 Benzinga

07:02AM EDT NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, PR Newswire

Oct 25, 2021

07:01AM EDT NuVasive Announces Conference Call and Webcast of Third Quarter 2021 Results PR Newswire

Oct 14, 2021

07:09AM EDT NuVasive Launches Latest Porous PEEK Implant For Posterior Spine Surgery Benzinga

Sep 30, 2021

07:07AM EDT NuVasive Announces First Commercial Cases Utilizing The Pulse Platform Benzinga

Sep 23, 2021

07:01AM EDT NuVasive Opens East Coast Experience Center in New York Metropolitan Area PR Newswire

Sep 22, 2021

07:01AM EDT NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond PR Newswire

Sep 9, 2021

07:11AM EDT NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery Benzinga

07:08AM EDT International Journal Of Spine Surgery Publishes NuVasive Simplify Cervical Disc Data RTTNews

07:01AM EDT NuVasive Simplify Cervical Disc Data Published In International Journal Of PR Newswire

06:00AM EDT Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021. GlobeNewswire Inc

Sep 1, 2021

04:13PM EDT NuVasive Announces Massimo Calafiore Appointed Chief Commercial Officer; Ryan Donahoe Appointed Chief Technology Officer Benzinga

04:10PM EDT NuVasive Announces New Executive Leadership Roles PR Newswire

Aug 30, 2021

07:01AM EDT NuVasive to Present at Upcoming Investor Conference PR Newswire

Aug 9, 2021

04:16PM EDT NuVasive Appoints Amy Belt Raimundo To Board Of Directors RTTNews

04:10PM EDT Amy Belt Raimundo to Join NuVasive Board of Directors PR Newswire

Jul 30, 2021

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

07:05AM EDT NuVasive Receives Latest FDA 510(k) Clearance For Pulse Platform RTTNews

07:00AM EDT NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces PR Newswire

Jul 29, 2021

10:24AM EDT UPDATE: Credit Suisse On NuVasive Post-Earnings: Firm Highlights 'Solid Improving Sequential Spine Growth' & Further Advances Driven By Pulse Navigation Launch, Roll-Out Of Simplify Cervical Disc Replacement, C360 Cervical Portfolio Uptake, & X360 Growth Benzinga

10:23AM EDT Credit Suisse Reiterates Outperform Rating On NuVasive Inc. With $84 Price Target Benzinga

Jul 28, 2021

04:16PM EDT NuVasive Reports Q2 EPS Of $0.03 Vs. Loss Per Share Of $0.95 Last Year RTTNews

04:14PM EDT NuVasive Sees FY21 Net Sales $1.19B-$1.21B Vs $1.2B Est.; Sees Non-GAAP EPS $2.25-$2.35 Vs $2.20 Est. Benzinga

04:13PM EDT NuVasive Q2 EPS $0.60 Beats $0.44 Estimate, Sales $294.80M Beat $285.08M Estimate Benzinga

04:10PM EDT NuVasive Announces Second Quarter 2021 Financial Results PR Newswire

04:27AM EDT Earnings Scheduled For July 28, 2021 Benzinga

Jul 22, 2021

07:01AM EDT NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior PR Newswire

Jul 14, 2021

04:11PM EDT NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results PR Newswire

Jul 9, 2021

09:51AM EDT FDA Flags Certain Biocompatibility Concerns For NuVasive's Orthopedics' Precice Devices Benzinga

Jun 30, 2021

07:37AM EDT NuVasive, Inc. (NUVA), a spine technology company, announced Wednesday that the Pulse platform received CE Mark approval for its latest design update. The company said clinical evaluations are underway in multiple countries throughout Europe. RTTNews

07:09AM EDT NuVasive Receives CE Mark Approval For Pulse Platform And Starts Global Clinical Evaluations Benzinga

07:04AM EDT NuVasive Gets CE Mark Approval For Pulse Platform; Clinical Evaluations Underway In Multiple Countries Throughout Europe RTTNews

07:01AM EDT NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global PR Newswire

May 19, 2021

04:03PM EDT NuVasive Appoints Daniel J. Wolterman as Independent Board Chair PR Newswire

May 10, 2021

04:04PM EDT NuVasive Appoints Juliet Cunningham As VP Of Investor Relations RTTNews

04:03PM EDT NuVasive Appoints Juliet C. Cunningham as Vice President of Investor Relations PR Newswire

May 7, 2021

08:29AM EDT Morgan Stanley Maintains Equal-Weight on NuVasive, Raises Price Target to $74 Benzinga

May 6, 2021

10:29AM EDT Piper Sandler Maintains Overweight on NuVasive, Raises Price Target to $80 Benzinga

07:40AM EDT Needham Maintains Buy on NuVasive, Raises Price Target to $80 Benzinga

May 5, 2021

04:14PM EDT NuVasive Q1 Adj. EPS $0.37 Beats $0.35 Estimate, Sales $271.20M Beat $261.77M Estimate Benzinga

04:05PM EDT NuVasive Q1 GAAP Loss Per Share $0.15; Non-GAAP EPS $0.37 RTTNews

04:03PM EDT NuVasive Announces First Quarter 2021 Financial Results PR Newswire

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

04:16AM EDT Earnings Scheduled For May 5, 2021 Benzinga

May 3, 2021

04:03PM EDT NuVasive to Present at Upcoming Investor Conferences PR Newswire

Apr 30, 2021

07:31AM EDT The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs Benzinga

Apr 29, 2021

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

Apr 27, 2021

07:41AM EDT The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout Benzinga

Apr 19, 2021

04:03PM EDT NuVasive Announces Conference Call and Webcast of First Quarter 2021 Results PR Newswire

10:54AM EDT Morgan Stanley Maintains Equal-Weight on NuVasive, Raises Price Target to $70 Benzinga

Apr 15, 2021

07:49AM EDT The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split Benzinga

Apr 6, 2021

04:40PM EDT NuVasive, Inc. (NUVA), Tuesday announced that the NuVasive Simplify Cervical Artificial Disc received approval from the U.S. Food and Drug Administration for two-level cervical total disc replacement. RTTNews

04:04PM EDT NuVasive's Simplify Disc Receives FDA Approval For Two-Level Cervical Total Disc Replacement RTTNews

04:04PM EDT NuVasive Announces Its Simplify Disc Receives FDA Approval For Two-Level Cervical Total Disc Replacement Benzinga

04:03PM EDT NuVasive's Simplify Disc Receives FDA Approval for Two-Level Cervical Total PR Newswire

Mar 25, 2021

04:05PM EDT NuVasive Announces Retirement Of Gregory Lucier From Board Of Directors RTTNews

07:45AM EDT Citigroup Maintains Buy on NuVasive, Raises Price Target to $80 Benzinga

Mar 19, 2021

07:46AM EDT The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs Benzinga

Mar 18, 2021

08:16AM EDT The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq Benzinga

Mar 16, 2021

08:38AM EDT NuVasive And International Spine Study Group Foundation Announce Initiation Of Additional Clinical Studies On 'improving patient outcomes in adult spinal deformity surgery' Benzinga

08:33AM EDT NuVasive and the International Spine Study Group Foundation Announce Expanded PR Newswire

Mar 1, 2021

09:22AM EST Morgan Stanley Maintains Equal-Weight on NuVasive, Raises Price Target to $65 Benzinga

Feb 25, 2021

04:42PM EST NuVasive Q4 EPS $0.59 Beats $0.55 Estimate, Sales $291.80M Miss $298.36M Estimate Benzinga

04:04PM EST NuVasive Q4 GAAP EPS $0.03; Non-GAAP EPS $0.59 RTTNews

04:03PM EST NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results PR Newswire

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 24, 2021

04:23PM EST NuVasive Reports Purchase Of Simplify Medical For $150M In Upfront Payment Benzinga

04:04PM EST NuVasive Acquires Simplify Medical RTTNews

Feb 18, 2021

08:33AM EST NuVasive to Present at the 41st Annual Cowen Health Care Conference PR Newswire

Feb 11, 2021

08:33AM EST NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year PR Newswire

Feb 8, 2021

08:35AM EST NuVasive Announces Planned Opening Of NuVasive East Coast Experience Center In Englewood, New Jersey, In Q3 RTTNews

08:33AM EST NuVasive Expands Clinical Professional Development Program with New East Coast PR Newswire

Feb 1, 2021

04:09PM EST NuVasive Appoints Siddhartha Kadia To Its Board Of Directors RTTNews

04:03PM EST Dr. Siddhartha Kadia to Join NuVasive Board of Directors PR Newswire

Jan 7, 2021

04:03PM EST NuVasive to Present at the 23rd Annual Needham Virtual Growth Conference PR Newswire

Jan 6, 2021

08:39AM EST NuVasive Says X360 Procedural Approach Validated In Clinical Study Published In The Spine Journal RTTNews

08:35AM EST NuVasive Reports Its X360 Procedural Approach In Study Published In The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications, Length Of Hospital Stay Benzinga

08:33AM EST The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Length of Hospital Stay PR Newswire

Jan 4, 2021

04:08PM EST NuVasive to Participate in 39th Annual Virtual J.P. Morgan Healthcare Conference PR Newswire

Dec 16, 2020

11:25AM EST Benzinga's Top Upgrades, Downgrades For December 16, 2020 Benzinga

08:32AM EST Citigroup Upgrades NuVasive to Buy Benzinga

Dec 15, 2020

12:40PM EST Morgan Stanley Maintains Equal-Weight on NuVasive, Raises Price Target to $53 Benzinga

07:44AM EST Wells Fargo Downgrades NuVasive to Underweight, Announces $48 Price Target Benzinga

Dec 7, 2020

08:33AM EST NuVasive to Feature its C360 Portfolio at the Cervical Spine Research Society PR Newswire

Nov 30, 2020

08:47AM EST NuVasive Unveils C360 Portfolio, Launches New Anterior Cervical Plate Benzinga

08:35AM EST NuVasive Launches New Anterior Cervical Plate RTTNews

08:33AM EST NuVasive Unveils C360 Portfolio and Launches New Anterior Cervical Plate PR Newswire

Nov 23, 2020

04:03PM EST NuVasive to Participate in the Piper Sandler 32nd Annual Virtual Healthcare PR Newswire

Nov 18, 2020

08:42AM EST NuVasive Announces Commercial Launch Of Cohere XLIF RTTNews

08:35AM EST NuVasive Announces Commercial Launch Of Cohere XLIF Interbody Benzinga

08:33AM EST NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody PR Newswire

Nov 9, 2020

08:37AM EST NuVasive Reports Co's Thoracolumbar Interbody Portfolio Receives First Clearance In U.S. For Treatment Of Sagittal Benzinga

08:35AM EST NuVasive's Thoracolumbar Interbody Portfolio Gets Clearance In US For Treatment Of Sagittal Deformities RTTNews

08:33AM EST NuVasive's Thoracolumbar Interbody Portfolio Receives First Clearance in the US PR Newswire

Nov 2, 2020

04:03PM EST NuVasive to Present at the Credit Suisse 29th Annual Virtual Healthcare PR Newswire

08:55AM EST Morgan Stanley Maintains Equal-Weight on NuVasive, Lowers Price Target to $52 Benzinga

Oct 30, 2020

12:39PM EDT BTIG Downgrades NuVasive to Neutral Benzinga

11:06AM EDT Canaccord Genuity Downgrades NuVasive to Hold, Lowers Price Target to $52 Benzinga

10:25AM EDT Shares of NuVasive, Inc. (NUVA), a developer of minimally disruptive surgical products for spine surgery, are declining more than 7 percent or $3.51 in Friday's morning trade at $45.76 despite its third-quarter results beating analysts' estimates. RTTNews

10:06AM EDT Benzinga's Top Upgrades, Downgrades For October 30, 2020 Benzinga

06:36AM EDT Baird Downgrades NuVasive to Neutral, Announces $56 Price Target Benzinga

05:13AM EDT SVB Leerink Maintains Outperform on NuVasive, Lowers Price Target to $65 Benzinga

Oct 29, 2020

05:22PM EDT NuVasive, Inc. (NUVA) released earnings for third quarter that declined from last year. RTTNews

04:24PM EDT NuVasive Q3 EPS $0.55 Beats $0.23 Estimate, Sales $295.30M Beat $256.11M Estimate Benzinga

04:04PM EDT NuVasive Q3 EPS $0.11 Vs. $0.21 Year Ago RTTNews

04:02PM EDT NuVasive Announces Third Quarter 2020 Financial Results PR Newswire

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 27, 2020

08:33AM EDT NuVasive to Participate as Gold Level Sponsor at SMISS Annual Forum PR Newswire

Oct 20, 2020

06:31AM EDT Stifel Initiates Coverage On NuVasive with Buy Rating, Announces Price Target of $64 Benzinga

Oct 19, 2020

04:03PM EDT NuVasive Announces Conference Call and Webcast of Third Quarter 2020 Results PR Newswire

Oct 16, 2020

11:18AM EDT NuVasive Option Alert: Nov 20 $60 Calls Sweep (14) near the Ask: 175 @ $2.39 vs 1448 OI; Earnings 10/28 After Close [est] Ref=$53.84 Benzinga

Oct 14, 2020

04:02PM EDT NuVasive Announces New Organizational Structure to Align Global Commercial PR Newswire

Oct 5, 2020

08:36AM EDT NuVasive Highlights MaXcess Retractor Featured In Study Further Validating Prone, Single-Position XLIF Published In The Journal Of Neurosurgery: Spine Benzinga

08:33AM EDT NuVasive MaXcess(r) Retractor Featured in Study Further Validating Prone, PR Newswire

Sep 9, 2020

08:36AM EDT NuVasive Announces Limited Availability Of The New Precice Plate RTTNews

08:33AM EDT NuVasive Expands Precice Portfolio with First-of-its-Kind Plate for Pediatric PR Newswire

Aug 31, 2020

04:03PM EDT NuVasive to Participate in Investor Events in September 2020 PR Newswire

Aug 4, 2020

04:32PM EDT NuVasive Q2 EPS $(0.40) Beats $(0.52) Estimate, Sales $203.60M Down From $292.11M YoY Benzinga

04:04PM EDT NuVasive Q2 GAAP Net Loss/Shr $0.98; Non-GAAP Net Loss/Shr $0.40 RTTNews

04:03PM EDT NuVasive Announces Second Quarter 2020 Financial Results PR Newswire

05:19AM EDT Earnings Scheduled For August 4, 2020 Benzinga

Jul 22, 2020

09:10AM EDT NuVasive' Invasive Procedural Solutions Proven To Reduce Operative Time And Improve Patient Outcomes In Spine Surgery RTTNews

08:34AM EDT NuVasive Launches 'Time to Evolve' Campaign Benzinga

08:33AM EDT NuVasive's Less Invasive Procedural Solutions Are Clinically Proven to Reduce PR Newswire

Jul 20, 2020

04:19PM EDT NuVasive To Report Operating Loss In Q2 - Quick Facts RTTNews

04:09PM EDT NuVasive Sees Q2 Sales $202M-$205M Vs. $151.58M Est. Benzinga

04:08PM EDT NuVasive Estimates Q2 Net Sales Of $202 Mln-$205 Mln, Down 30% From Last Year RTTNews

04:06PM EDT NuVasive Announces Certain Preliminary Unaudited Second Quarter 2020 Results PR Newswire

Jul 17, 2020

08:33AM EDT NuVasive Becomes First Industry Sponsor of the American Spine Registry to PR Newswire

Share